A search of PubMed, the Natural Medicines Comprehensive Database, and the FDA Adverse Event Reporting System (FAERS) through May 2026 returns zero case reports, zero pharmacokinetic studies, and zero mechanistic papers describing an interaction between glutathione (any route) and minoxidil (any route) [7]
Promrat K, Kleiner DE, Niemeier HM, et al
M.MurphyL
Ratios of log 2 -normalized transcript count data were generated for SLD Dpp4 / mice versus baseline SLD WT mice, HFHC-fed Dpp4 / mice versus baseline HFHC-fed WT mice, and HFHC-fed Dpp4 hep/ mice versus baseline HFHC-fed Dpp4 GFP mice
Final Takeaway The FDAs 2026 peptide announcement is best understood as a regulatory review, not a one-step answer on peptide access or use
10.2147/OTT.S222702 Onco Targets Ther